Eye implant could replace daily drops for glaucoma patients
NCT ID NCT04060758
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a tiny implant placed inside the eye that slowly releases medication to lower eye pressure in people with mild-to-moderate open-angle glaucoma. The goal was to find a dose that works well with few side effects. 37 adults took part, and researchers monitored safety and pressure-lowering effects over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN-ANGLE GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bendigo Eye Clinic
Bendigo, Victoria, 3550, Australia
-
Capital Eye Specialists
Te Aro, 6011, New Zealand
-
Centre for Eye Research Australia
East Melbourne, Victoria, 3002, Australia
-
Essendon Eye Clinic
Essendon, Victoria, 3040, Australia
-
Eye Surgery Associates
Vermont South, Victoria, 3133, Australia
-
Eyes First
Springvale, Victoria, 3171, Australia
-
Goodwood Eye Centre
Millswood, South Australia, 5034, Australia
-
Melbourne Eye Specialists
Fitzroy, Victoria, 3065, Australia
-
PersonalEYES
Castle Hill, New South Wales, 2150, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new eye test match the gold standard for glaucoma?
- Which laser best tames glaucoma pressure?
- Could a single eye implant replace years of glaucoma drops?
- Eye implant could offer long-term pressure control for glaucoma patients
- Glaucoma implant MINIject put to the test in everyday eye clinics
- Glaucoma implant could replace daily eye drops